NHI approved 3 schizophrenia drugs.

The MOHW revised "Standards for NHI payment and its detailed particulars" on Jan. 31 to take effect from Feb. 1, covering that 3 schizophrenia drugs, Aricept (donepezil), Reminyl (galantamine) and Exelon (rivastigmine) and other 6 drugs such as Zoloft and Seroxat were listed to the NHI reimbursement scheme.

Aricept was approved for the indications of moderate and sever schizophrenia and vas...